Cargando…

Platelet‐Derived Growth Factor Receptor Type α Activation Drives Pulmonary Vascular Remodeling Via Progenitor Cell Proliferation and Induces Pulmonary Hypertension

BACKGROUND: Platelet‐derived growth factor is a major regulator of the vascular remodeling associated with pulmonary arterial hypertension. We previously showed that protein widely 1 (PW1(+)) vascular progenitor cells participate in early vessel neomuscularization during experimental pulmonary hyper...

Descripción completa

Detalles Bibliográficos
Autores principales:	Solinc, Julien, Raimbault‐Machado, Jessica, Dierick, France, El Bernoussi, Lamiaa, Tu, Ly, Thuillet, Raphaël, Mougenot, Nathalie, Hoareau‐Coudert, Bénédicte, Monceau, Virginie, Pavoine, Catherine, Atassi, Fabrice, Sassoon, David, Marazzi, Giovanna, Harvey, Richard P., Schofield, Peter, Christ, Daniel, Humbert, Marc, Guignabert, Christophe, Soubrier, Florent, Nadaud, Sophie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075467/ https://www.ncbi.nlm.nih.gov/pubmed/35348002 http://dx.doi.org/10.1161/JAHA.121.023021

Ejemplares similares

The Platelet-Derived Growth Factor Pathway in Pulmonary Arterial Hypertension: Still an Interesting Target?
por: Solinc, Julien, et al.
Publicado: (2022)

Progenitor/Stem Cells in Vascular Remodeling during Pulmonary Arterial Hypertension
por: Dierick, France, et al.
Publicado: (2021)

Pulmonary hypertension associated with neurofibromatosis type 2
por: Taniguchi, Hirohisa, et al.
Publicado: (2021)

Preventing the Increase in Lysophosphatidic Acids: A New Therapeutic Target in Pulmonary Hypertension?
por: Duflot, Thomas, et al.
Publicado: (2021)

Cardiac inflammatory CD11b/c cells exert a protective role in hypertrophied cardiomyocyte by promoting TNFR(2)- and Orai3- dependent signaling
por: Keck, Mathilde, et al.
Publicado: (2019)

Early activation of the cardiac CX3CL1/CX3CR1 axis delays β-adrenergic-induced heart failure
por: Flamant, M., et al.
Publicado: (2021)

Macrophage Migration Inhibitory Factor (MIF) Inhibition in a Murine Model of Bleomycin-Induced Pulmonary Fibrosis
por: Günther, Sven, et al.
Publicado: (2018)

Inhibition of Soluble Epoxide Hydrolase Does Not Promote or Aggravate Pulmonary Hypertension in Rats
por: Leuillier, Matthieu, et al.
Publicado: (2023)

Pathogenesis of pulmonary arterial hypertension: lessons from cancer
por: Guignabert, Christophe, et al.
Publicado: (2013)

Renal Denervation Reduces Pulmonary Vascular Remodeling and Right Ventricular Diastolic Stiffness in Experimental Pulmonary Hypertension
por: da Silva Gonçalves Bos, Denielli, et al.
Publicado: (2017)

Purinergic Dysfunction in Pulmonary Arterial Hypertension
por: Cai, Zongye, et al.
Publicado: (2020)

A genome-wide association analysis identifies PDE1A|DNAJC10 locus on chromosome 2 associated with idiopathic pulmonary arterial hypertension in a Japanese population
por: Kimura, Mai, et al.
Publicado: (2017)

Precision medicine and personalising therapy in pulmonary hypertension: seeing the light from the dawn of a new era
por: Savale, Laurent, et al.
Publicado: (2018)

An endothelial activin A-bone morphogenetic protein receptor type 2 link is overdriven in pulmonary hypertension
por: Ryanto, Gusty R. T., et al.
Publicado: (2021)

Early Protective Role of Inflammation in Cardiac Remodeling and Heart Failure: Focus on TNFα and Resident Macrophages
por: Besse, Sophie, et al.
Publicado: (2022)

Dendritic Cells in Pulmonary Hypertension: Foot Soldiers or Hidden Enemies?
por: Guignabert, Christophe
Publicado: (2020)

N-acetylcysteine improves established monocrotaline-induced pulmonary hypertension in rats
por: Chaumais, Marie-Camille, et al.
Publicado: (2014)

Inhalable delivery of AAV-based MRP4/ABCC4 silencing RNA prevents monocrotaline-induced pulmonary hypertension
por: Claude, Caroline, et al.
Publicado: (2015)

Screening for pulmonary arterial hypertension in adults carrying a BMPR2 mutation
por: Montani, David, et al.
Publicado: (2021)

Transcriptomic and Lipidomic Mapping of Macrophages in the Hub of Chronic Beta-Adrenergic-Stimulation Unravels Hypertrophy-, Proliferation-, and Lipid Metabolism-Related Genes as Novel Potential Markers of Early Hypertrophy or Heart Failure
por: Nadaud, Sophie, et al.
Publicado: (2022)

Identifying new drugs associated with pulmonary arterial hypertension: A WHO pharmacovigilance database disproportionality analysis
por: Hlavaty, Alex, et al.
Publicado: (2022)

Arsenic trioxide demonstrates efficacy in a mouse model of preclinical systemic sclerosis
por: Cauvet, Anne, et al.
Publicado: (2023)

Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives
por: Humbert, Marc, et al.
Publicado: (2019)

Anti-integrin α(v) therapy improves cardiac fibrosis after myocardial infarction by blunting cardiac PW1(+) stromal cells
por: Bouvet, Marion, et al.
Publicado: (2020)

The dimerisable Cre recombinase allows conditional genome editing in the mosquito stages of Plasmodium berghei
por: Fernandes, Priyanka, et al.
Publicado: (2020)

Editorial: Molecular Mechanisms in Pulmonary Hypertension and Right Ventricle Dysfunction
por: Karmouty-Quintana, Harry, et al.
Publicado: (2018)

Absence of influence of gender and BMPR2 mutation type on clinical phenotypes of pulmonary arterial hypertension
por: Girerd, Barbara, et al.
Publicado: (2010)

The extraocular muscle stem cell niche is resistant to ageing and disease
por: Formicola, Luigi, et al.
Publicado: (2014)

Illuminating the Importance of Pulmonary Arterial Compliance in Pulmonary Hypertension
por: Weatherald, Jason, et al.
Publicado: (2023)

Smooth muscle Rac1 contributes to pulmonary hypertension
por: Dilasser, Florian, et al.
Publicado: (2022)

Different cardiovascular and pulmonary phenotypes for single- and double-knock-out mice deficient in BMP9 and BMP10
por: Bouvard, Claire, et al.
Publicado: (2021)

Altered TGFβ/SMAD Signaling in Human and Rat Models of Pulmonary Hypertension: An Old Target Needs Attention
por: Sanada, Takayuki Jujo, et al.
Publicado: (2021)

Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)?
por: Huertas, Alice, et al.
Publicado: (2020)

Progression of pulmonary veno‐occlusive disease without pulmonary hypertension
por: Beshay, Sarah, et al.
Publicado: (2022)

Loss of a single allele for Ku80 leads to progenitor dysfunction and accelerated aging in skeletal muscle
por: Didier, Nathalie, et al.
Publicado: (2012)

The Long March to a Cure for Pulmonary Hypertension
por: Humbert, Marc
Publicado: (2022)

The claudin-like apicomplexan microneme protein is required for gliding motility and infectivity of Plasmodium sporozoites
por: Loubens, Manon, et al.
Publicado: (2023)

Risk assessment in pulmonary arterial hypertension
por: Raina, Amresh, et al.
Publicado: (2016)

Seeing the Forest for the (Arterial) Tree: Vascular Pruning and the Chronic Obstructive Pulmonary Disease Pulmonary Vascular Phenotype
por: Weatherald, Jason, et al.
Publicado: (2019)

Rare pulmonary diseases: a common fight
por: Harari, Sergio, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_d5lph57gra3hkdffosea0hq7qn